Axon Enterprise - AXON Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $168.25
  • Forecasted Upside: -1.02 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 6 Buy Ratings
  • 0 Strong Buy Ratings
$169.99
▲ +0.56 (0.33%)

This chart shows the closing price for AXON by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Axon Enterprise Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AXON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AXON

Analyst Price Target is $168.25
▼ -1.02% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Axon Enterprise in the last 3 months. The average price target is $168.25, with a high forecast of $200.00 and a low forecast of $130.00. The average price target represents a -1.02% upside from the last price of $169.99.

This chart shows the closing price for AXON for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 polled investment analysts is to buy stock in Axon Enterprise.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/15/2021
  • 1 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/13/2021
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/12/2021
  • 1 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/12/2022
  • 1 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/10/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/8/2022
  • 0 strong buy ratings
  • 8 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/7/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/7/2022

Latest Recommendations

  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/15/2022Robert W. BairdBoost Target$170.00N/A
11/9/2022Northland SecuritiesBoost Target$140.00 ➝ $160.00Low
11/9/2022Needham & Company LLCBoost TargetBuy$130.00 ➝ $200.00Low
11/9/2022Morgan StanleyBoost TargetEqual Weight$120.00 ➝ $130.00Low
11/9/2022Credit Suisse GroupBoost TargetOutperform$142.00 ➝ $152.00N/A
9/15/2022BarclaysInitiated CoverageOverweight$147.00Low
8/18/2022Robert W. BairdBoost TargetOutperform$130.00 ➝ $150.00Low
8/10/2022Credit Suisse GroupBoost TargetOutperform$134.00 ➝ $142.00Low
7/14/2022Credit Suisse GroupLower Target$169.00 ➝ $134.00Low
6/1/2022JMP SecuritiesReiterated RatingBuy$195.00Low
5/23/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$120.00High
5/12/2022Northland SecuritiesLower Target$180.00 ➝ $130.00High
5/11/2022Robert W. BairdLower Target$145.00 ➝ $125.00High
5/9/2022Credit Suisse GroupInitiated CoverageOutperform$169.00Medium
2/28/2022Northland SecuritiesLower Target$220.00 ➝ $180.00High
2/25/2022Robert W. BairdReiterated RatingBuy$175.00High
2/25/2022JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$222.00 ➝ $192.00High
2/25/2022Needham & Company LLCLower TargetBuy$250.00 ➝ $170.00High
12/15/2021Morgan StanleyLower TargetOverweight$200.00 ➝ $180.00Low
12/14/2021JMP SecuritiesInitiated CoverageOutperform$195.00High
11/16/2021William BlairReiterated RatingOutperformHigh
11/16/2021Craig HallumUpgradeHold ➝ Buy$232.00High
8/6/2021Raymond JamesBoost TargetStrong-Buy$200.00 ➝ $223.00Medium
8/6/2021Needham & Company LLCBoost TargetBuy$190.00 ➝ $250.00Low
8/6/2021Robert W. BairdBoost TargetPositive ➝ Outperform$195.00 ➝ $220.00High
6/30/2021Raymond JamesBoost TargetStrong-Buy$150.00 ➝ $200.00Low
5/19/2021Raymond JamesUpgradeMarket Perform ➝ Strong-Buy$150.00High
2/26/2021Northland SecuritiesInitiated CoverageBuy$170.00Medium
2/26/2021Needham & Company LLCReiterated RatingBuyHigh
2/26/2021Robert W. BairdBoost TargetOutperform$135.00 ➝ $200.00High
2/12/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$129.00 ➝ $179.00Low
2/1/2021Morgan StanleyInitiated CoverageOverweight$185.00Low
10/23/2019JMP SecuritiesReiterated RatingOutperform$28.00 ➝ $32.00Low
2/11/2019JMP SecuritiesReiterated RatingBuy$6.00Medium
12/17/2018Jefferies Financial GroupUpgradeHold ➝ Buy$3.00High
11/11/2018OppenheimerReiterated RatingHoldHigh
9/20/2018CowenReiterated RatingHoldLow
8/13/2018HC WainwrightReiterated RatingBuy$7.00Medium
7/9/2018OppenheimerReiterated RatingHoldLow
6/12/2018OppenheimerReiterated RatingHoldLow
6/11/2018Jefferies Financial GroupBoost TargetHold$3.00 ➝ $5.00High
6/7/2018HC WainwrightReiterated RatingBuyHigh
6/6/2018OppenheimerReiterated RatingHoldHigh
6/6/2018Chardan CapitalReiterated RatingHold$4.00High
2/13/2018CowenReiterated RatingHoldHigh
2/13/2018OppenheimerReiterated RatingHoldHigh
1/12/2018CowenDowngradeOutperform ➝ Market PerformHigh
1/10/2018Chardan CapitalUpgradeSell ➝ Neutral$2.50 ➝ $2.50Low
12/21/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$6.00High
(Data available from 12/7/2017 forward)

News Sentiment Rating

0.77 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
5/11/2022
  • 6 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/10/2022
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/10/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
8/9/2022
  • 6 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
9/8/2022
  • 4 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/8/2022
  • 3 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
11/7/2022
  • 17 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
12/7/2022

Current Sentiment

  • 17 very positive mentions
  • 16 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Axon Enterprise logo
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness, including streamlined investigative workflows. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
Read More

Today's Range

Now: $169.99
Low: $168.77
High: $171.49

50 Day Range

MA: $155.27
Low: $119.45
High: $192.14

52 Week Range

Now: $169.99
Low: $82.49
High: $193.85

Volume

27,108 shs

Average Volume

609,931 shs

Market Capitalization

$12.10 billion

P/E Ratio

117.23

Dividend Yield

N/A

Beta

0.75

Frequently Asked Questions

What sell-side analysts currently cover shares of Axon Enterprise?

The following equities research analysts have issued reports on Axon Enterprise in the last twelve months: Barclays PLC, Credit Suisse Group AG, JMP Securities, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Northland Securities, Robert W. Baird, and StockNews.com.
View the latest analyst ratings for AXON.

What is the current price target for Axon Enterprise?

8 Wall Street analysts have set twelve-month price targets for Axon Enterprise in the last year. Their average twelve-month price target is $168.25, suggesting a possible downside of 1.0%. Needham & Company LLC has the highest price target set, predicting AXON will reach $200.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $130.00 for Axon Enterprise in the next year.
View the latest price targets for AXON.

What is the current consensus analyst rating for Axon Enterprise?

Axon Enterprise currently has 1 hold rating and 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AXON will outperform the market and that investors should add to their positions of Axon Enterprise.
View the latest ratings for AXON.

What other companies compete with Axon Enterprise?

How do I contact Axon Enterprise's investor relations team?

Axon Enterprise's physical mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The biotechnology company's listed phone number is (480) 991-0797 and its investor relations email address is [email protected] The official website for Axon Enterprise is www.axovant.com. Learn More about contacing Axon Enterprise investor relations.